Beyond Collaboration: How Partnerships Drive Women's Health Innovation
- 10 hours ago
- 6 min read
A lot of organizations collaborate, but few take the time to build true partnerships.
"It requires discussion, negotiation, communication, and a shared goal," says Dr. Patricia Garcia, Professor of Public Health at la Universidad Peruana Cayetano Heredia, former Minister of Health of Peru, and longtime collaborator with the Duke Center for Global Women's Health Technologies (GWHT). Over the past decade, GWHT has learned that technologies create impact only when they are built alongside the people and systems that will use them.
For Garcia, the distinction matters because solving complex healthcare challenges requires more than a new technology. It requires researchers, clinicians, governments, healthcare systems, and communities working together toward a common purpose.
At GWHT, partnerships are not simply collaborators on a project. They are a core component of how technologies move from innovation to implementation and long-term impact.
When Technology Isn't Enough
When GWHT Director Nimmi Ramanujam founded the center, she envisioned engineering as one tool among many for improving women's health.
"Engineering is just a piece," she says. "It's a tool."
Over time, that philosophy was reinforced through experience. Technologies that performed well in controlled environments often encountered unexpected challenges in real healthcare settings. Clinical workflows, provider needs, cultural contexts, and health system realities all influenced whether a solution could succeed.
"Technology no longer was the only solution," Ramanujam says.
The lesson was clear: innovation requires partnership.
Not just after a technology is developed, but throughout the entire process.
A Shared Problem in Peru
Prof. Garcia first met Prof. Ramanujam at a global health conference while presenting a challenge she was facing in Peru.
Her team had successfully expanded access to HPV testing, helping identify women at risk for cervical cancer earlier. Yet a major gap remained.
Once women tested positive, many communities lacked access to specialists and follow-up care.
"I was presenting my frustrations," Prof. Garcia recalls. "We had the policy, but nobody was implementing it."
After the presentation, Ramanujam approached her.
The two quickly realized they brought complementary expertise to the problem. Garcia's team had extensive experience in public health implementation, community engagement, and healthcare systems. Ramanujam's team was developing technologies designed to expand access to cervical cancer screening and diagnosis.
Together, they built a partnership focused on solving a shared challenge.
The partnership also created an environment where technologies could be developed and refined alongside the people and healthcare systems that would ultimately use them. Rather than designing solutions in isolation, researchers, clinicians, and community partners worked together to ensure that innovations addressed real-world needs.
Before proposals were finalized, local government officials, healthcare providers, and community members helped shape how the program would work.
"We talked with them before we even started writing the proposal," Garcia says. For GWHT, this became a defining lesson: partnerships work best when they begin before the technology is deployed or even before the proposal is written.
That early involvement proved critical.
Using a combination of HPV self-sampling, cervical imaging, and local treatment pathways, the team created a model that allowed approximately 85 percent of women to receive care close to home rather than traveling to distant specialty centers.
Perhaps more importantly, the work continued after the initial project ended.
Because local partners were involved from the beginning, elements of the program remain active today.
"Partnership means communication, means sharing a goal, means negotiation and understanding from each other," Garcia says. "Although it takes time, it helps ensure things continue."
Learning Together in Kenya
In Kenya, the partnership has evolved through more than a decade of collaboration between the Kenya Medical Research Institute (KEMRI) and Duke.
For Dr. Francesca Odhiambo, a Clinical Research Scientist at KEMRI, the partnership's impact can be seen across the entire cervical cancer prevention pathway—from education and screening to follow-up and treatment.
Together, teams have explored HPV self-sampling, community-based screening, mobile health tools, educational interventions, and AI-assisted cervical imaging.
"Our partnership with GWHT is more than a research collaboration," Odhiambo says. "It is a long-standing, trust-based partnership focused on improving women's health in meaningful and sustainable ways."
Many of those innovations were shaped by feedback from healthcare workers and patients themselves.
For Florence Mawere, a public health researcher working on cervical cancer prevention through KEMRI, the value of collaboration comes from bringing different forms of expertise together.
"I see them on AI and technology, and I am on the front line," she says.
Through the partnership, laboratory testing, clinical evaluations, imaging technologies, and artificial intelligence tools work together to support earlier detection and treatment.
"For me, that's a very good collaboration because now this is lab, this is AI technology meeting lab outcomes."
Healthcare providers contribute feedback that helps researchers improve technologies and workflows. Researchers refine training methods and algorithms based on what providers experience in the clinic. Community members help shape how technologies are introduced and understood.
As Prof. Ramanujam describes the process as a continuous cycle of learning: "It becomes a symbiotic relationship."
These partnerships also create opportunities for the next generation of translational innovators. Through collaborations with organizations such as KEMRI and partners in Peru, students, translational fellows, and researchers gain firsthand experience working at the intersection of technology development, clinical implementation, and community engagement. Rather than learning about deployment in a classroom, they participate directly in the process of moving innovations into real-world healthcare settings.
"Trust is central to the successful introduction of new healthcare technologies. When trust is present, new technologies are more likely to be accepted, used correctly, and sustained." Dr. Francesca Odhiambo, Clinical Research Scientist, KEMRI
Building Trust
For clinicians on the front lines, trust may be the most important technology of all.
Jenipher Ambaka, a clinical officer and study coordinator with KEMRI's Cervical Cancer Screening and Prevention Study, sees firsthand how trust influences whether women seek screening and care.
"The moment you win the woman's soul, then she's able to open up to you," Ambaka says.
That trust helps healthcare providers address misinformation, stigma, and fear surrounding cervical cancer screening.
Some women worry that screening procedures can cause cancer to spread. Others believe HPV vaccination may harm their children. Many fear receiving a positive test result.
To address those concerns, providers use tools to support counseling and education. They use an app with videos, audio resources, and patient stories that help women understand what screening involves and what happens after diagnosis.
"We have women who fear the unknown," Ambaka says. "But immediately they get a video of someone who's gone through the screening and treatment, they open up. They say, 'If she can do it, then I can also.'"
For clinicians like Ambaka and Winifred Mokiri, these conversations are not abstract.
Mokiri regularly sees women delay screening because they fear what a diagnosis might mean. Others arrive only after symptoms appear, sometimes with advanced disease that is much more difficult to treat.
"I have lost two close people due to cervical cancer," Mokiri says.
Experiences like these reinforce a lesson that all the partners have learned over time: technology alone cannot improve outcomes.
Trust, education, and community engagement are equally important.
"Trust is central to the successful introduction of new healthcare technologies," Odhiambo says. "When trust is present, new technologies are more likely to be accepted, used correctly, and sustained."
Building for Impact
For all these collaborators, successful innovation depends on bringing different forms of expertise together.
Researchers contribute technology development. Clinicians contribute patient care experience. Governments contribute pathways for implementation. Communities contribute local knowledge, trust, and long-term sustainability.
Each perspective strengthens the final solution.
"It's good to think about partnerships in which both sides bring something to the table," Garcia says. "We're complementary."
That belief has become central to GWHT's approach.
The goal is not simply to develop new technologies. It is to create systems that allow those technologies to succeed in real healthcare environments and continue creating impact long after a research project ends.
For GWHT, partnerships are not a supporting activity. They are the mechanism through which innovation becomes impact.
The center's experience in Peru and Kenya has shown that sustainable healthcare solutions emerge when technologies are developed alongside clinicians, communities, governments, and health systems.
Successful innovation is not measured only by what is invented. It is measured by what is adopted, trusted, sustained, and ultimately improves lives.
That is the role partnerships play: helping ideas move beyond research and into lasting healthcare impact.
Comments